Back to products
Diabetic
- All products
- Hepatitis B Virus28 products
Bladder Cancer39 products
Breast Cancer38 products
- Colorectal Cancer28 products
Diabetic25 products
- Endometrial Cancer29 products
- Hepatitis C Virus21 products
- Leukaemia3 products
- ONCOLOGY PRODUCTS29 products
- Rectal Cancer16 products
- Solid Tumor6 products
- Taskin50 products
- Anti-Diabetic6 products
- BEST SELLER16 products
- Bladder Cancer19 products
- Breast Cancer19 products
- Colon & Rectal Cancer12 products
- Colorectal Cancer10 products
- Diabetic12 products
- Endometrial Cancer13 products
- Hepatitis B Virus7 products
- Hepatitis C Virus9 products
- Ibrutinib4 products
- Kidney Cancer22 products
- Leukaemia12 products
- Liver Cancer22 products
- Lung Cancer24 products
- Lymphoma13 products
- Mantle Cell Lymphoma11 products
- Melanoma12 products
- Non-Hodgkin7 products
- ONCOLOGY18 products
- ONCOLOGY PRODUCTS41 products
- Tumor2 products
ELBONIX 50 MG
COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
HEPANIB 200 MG
Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd. Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
JUPARIB 150 MG
Juparib Tablet Olaparib 150 mg Julphar Bangladesh Ltd. Also available as: 100 mg Indications Breast Cancer: Olaparib is indicated as monotherapy
LARONIB 100 MG
DESCRIPTION Laronib Larotrectinib 25 mg & 100 mg COMPOSITION LARONIB 25 capsules: Each capsule contains Larotrectinib Sulfate INN equivalent to
LENVANIX 4 MG
Lenvanix (lenvatinib) 4 Mg Product Description: First new frontline treatment option for HCC approved in Japan Lenvatinib is amultikinase inhibitor
LEVAT 10 MG
Levat Capsule Lenvatinib Mesylate 10 mg Julphar Bangladesh Ltd. Indications Lenvatinib is a kinase inhibitor that is indicated: For the treatment
NIRANIB 100 MG
DESCRIPTION Niranib Niraparib 100 mg Everest Pharmaceuticals Ltd. Bangladesh COMPOSITION NIRANIB Capsule: Each capsule contains Niraparib Tosylate Monohydrate INN equivalent
OLANIB 150 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have
OLANIB 50 MG
DESCRIPTION Olanib (Olaparib) Olanib is used for the returning treatment of some types of ovarian cancer in patients who have
PALBOCENT 125 MG
DESCRIPTION Palbocent Palbociclib 125 mg Capsules Incepta Pharmaceuticals Limited Indications Palbociclib is a kinase inhibitor indicated for the treatment of
RESOLAX 1 MG
Resolax Tablet Prucalopride Succinate 1 mg Everest Pharmaceuticals Ltd. Indications Prucalopride is indicated for symptomatic treatment of chronic constipation in adults
ROXIBAC PLUS
Roxibac Plus Tablet Cefuroxime Axetil + Clavulanic Acid 250 mg+62.5 mg & 500Mg Julphar Bangladesh Ltd. Indications It is indicated for
